The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
Bioequivalence studies are an essential component in the development and approval of generic pharmaceutical products, ensuring that they perform similarly to their reference counterparts. These ...
Their method, called the Frequency-Adaptive Mixture of Experts Network (FAME-Net), has been accepted for publication in the 2024 proceedings of the Association for the Advancement of Artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback